These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25701027)

  • 21. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
    Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
    Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
    Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
    J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
    Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
    Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
    J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
    Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
    Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
    Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
    J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.
    Yu H; Guo C; Feng B; Liu J; Chen X; Wang D; Teng L; Li Y; Yin Q; Zhang Z; Li Y
    Theranostics; 2016; 6(1):14-27. PubMed ID: 26722370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionalized nanospheres for targeted delivery of paclitaxel.
    Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
    J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-delivery of docetaxel and silibinin using pH-sensitive micelles improves therapy of metastatic breast cancer.
    Dong XY; Lang TQ; Yin Q; Zhang PC; Li YP
    Acta Pharmacol Sin; 2017 Dec; 38(12):1655-1662. PubMed ID: 28713159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers.
    Mendes LP; Sarisozen C; Luther E; Pan J; Torchilin VP
    Drug Deliv; 2019 Dec; 26(1):443-458. PubMed ID: 30929529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X; Mo R; Ding Y; Zheng W; Zhang C
    Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
    Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
    J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.